NSCLC (NSCLC) patients, particularly, have been seeing repeated osimertinib become a vital component in the continuous fight against cancer.Osimertinib, as a precision therapy, has demonstrated remarkable effectiveness in treating patients with EGFR alterations, bringing hope for extended survival.The concept of repeating this medication prompts several important questions and thoughts.This article explores the consequences of repeating osimertinib by addressing four main aspects associated with it.Understanding the How Osimertinib WorksThe EGFR (EGFR) tyrosine kinase enzyme, a protein that promotes the growth and proliferation of cancer cells, is inhibited by osimertinib, an oral…
